电子邮件 | ema***@***.com | 获取Email |
---|
电子邮件 | ema***@***.com | 获取Email |
---|
We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion's spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric conditions. Sunovion's track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at www.sunovion.com and connect on Twitter and Facebook @Sunovion. LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd. APTIOM is used under license from BIAL. KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc. © 2023 Sunovion Pharmaceuticals Inc. To view our community guidelines, see here: bit.ly/3CozDLX
公司 | Sunovion Pharmaceuticals |
---|---|
职位 | Director, Brand & Market Access Insights Business Partner |
地点 | United States |
http://www.linkedin.com/in/michael-zennario-002b6b5 | |
部门 | master_marketing |
头衔 | Director, Market Access Insights Business Partner |
Sumitomo Pharma America, Inc. Commercial Insights & Analytics Lead, Women's Health
2023-07-01 -
Sunovion Pharmaceuticals Director, Brand & Market Access Insights Business Partner
2021-08-01 - 2023-07-01
Sunovion Pharmaceuticals Director, Brand & Market Access Insights Business Partner
2021-08-01 -
Otsuka Pharmaceutical Companies (U.S.) Associate Director, Payer Analytics
2019-05-01 - 2021-07-01
Otsuka Pharmaceutical Companies (U.S.) Associate Director, Payer Analytics
2019-05-01 - 2021-07-01
Michael Zennario 在 Sunovion Pharmaceuticals 担任 Director, Market Access Insights Business Partner
Michael Zennario 在 Sunovion Pharmaceuticals 的职位是 Director, Market Access Insights Business Partner
Michael Zennario 的电子邮件地址是 ema***@***.com
Michael Zennario 的电话号码是 -
Michael Zennario 的公司电话号码是 +150****
Michael Zennario 在 pharmaceuticals 工作。
Michael Zennario 的一些同事包括Kevin Fang、Pamela Krengel、Cathy May、Mimi MYenfher C、。
Michael Zennario联系方式: 电子邮件地址:ema***@***.com 电话号码:-
Michael Zennario 的个人领英是:http://www.linkedin.com/in/michael-zennario-002b6b5
Michael Zennario 的办公地点:84 waterford drive, marlborough, massachusetts, united states
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd